The Food and Drug Administration doesn’t intend for a potential mandatory product listing requirement for dietary supplements to a barrier to additional products reaching the US market, says Office of Dietary Supplements Program director Cara Welch.
“We are not looking to establish a waiting period where we can confirm the lawfulness of the products before they're listed or marketed,” Welch said on 21 July at the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?